Introduction Although the administration of activated charcoal (AC) is considered safe, the associated risk of pulmonary ...

The transition to adult healthcare is a vulnerable period for young people (YP) with chronic conditions linked to ...

1 Department of Paediatric Endocrinology, University Hospital Southampton, Southampton, UK 2 Department of Endocrinology and Diabetes, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, ...

Department of Paediatric Intensive Care, Guy’s Hospital, London SE1 9RT, UK Dr S Tibby, Department of Paediatric Intensive Care, Guy’s Hospital, London SE1 9RT, UK; Shane.Tibby{at}gstt.sthames.nhs.uk ...

2 Department of Public Health, University of Liverpool, Liverpool, UK Correspondence to: Prof. P O D Pharoah Department of Public Health, University of Liverpool, Liverpool L69 3GB, UK; ...

Dubowitz Neuromuscular Centre, Department of Paediatric Neurology, Great Ormond Street Hospital for Children, Institute of Child Health, London, UK Dr Adnan Y Manzur, Great Ormond Street Hospital for ...

and reprint requests to: Dr Alastair J Baker, Department of Child Health, King’s College Hospital, Denmark Hill, London SE5 9RS. Hepatitis GB virus-C (HGBV-C)/hepatitis G virus (HGV) infection was ...

Objective To assess the pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents with tuberculous meningitis (TBM). Design Prospective ...

2 Department of Practice and Policy, The School of Pharmacy, University of London, Mezzanine, BMA House, London, UK 3 Centre for Medication Safety and Service Quality, Imperial College Healthcare NHS ...

Department of Endocrinology and Diabetes, Royal Children’s Hospital, Parkville, Victoria, Australia and reprint requests to: Dr Margaret R Zacharin, Department of Endocrinology, Royal Children’s ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

AIMS To delineate common and variable features and outcome of children with congenital disorder of glycosylation type Ia (CDG-Ia) caused by the frequent R141H/F119LPMM2 genotype. METHODS Clinical data ...